BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17710900)

  • 1. First trimester anesthesia exposure and fetal outcome. A review.
    Allaert SE; Carlier SP; Weyne LP; Vertommen DJ; Dutré PE; Desmet MB
    Acta Anaesthesiol Belg; 2007; 58(2):119-23. PubMed ID: 17710900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonobstetric surgery during pregnancy: what are the risks of anesthesia?
    Kuczkowski KM
    Obstet Gynecol Surv; 2004 Jan; 59(1):52-6. PubMed ID: 14707749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-trimester exposure to alprazolam.
    St Clair SM; Schirmer RG
    Obstet Gynecol; 1992 Nov; 80(5):843-6. PubMed ID: 1407925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcome following in utero exposure to bisphosphonates.
    Levy S; Fayez I; Taguchi N; Han JY; Aiello J; Matsui D; Moretti M; Koren G; Ito S
    Bone; 2009 Mar; 44(3):428-30. PubMed ID: 19059370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.
    Bar-Oz B; Diav-Citrin O; Shechtman S; Tellem R; Arnon J; Francetic I; Berkovitch M; Ornoy A
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):31-4. PubMed ID: 18760873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Teratological counseling in Israel].
    Ornoy A; Arnon J
    Harefuah; 1991 May; 120(10):567-73. PubMed ID: 1937190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the combined first-trimester screen result and low PAPP-A to predict risk of adverse fetal outcomes.
    Barrett SL; Bower C; Hadlow NC
    Prenat Diagn; 2008 Jan; 28(1):28-35. PubMed ID: 18186146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anesthesia for nonobstetric surgery during pregnancy.
    Beilin Y
    Mt Sinai J Med; 1998 Sep; 65(4):265-70. PubMed ID: 9757746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal smoking and congenital heart defects.
    Malik S; Cleves MA; Honein MA; Romitti PA; Botto LD; Yang S; Hobbs CA;
    Pediatrics; 2008 Apr; 121(4):e810-6. PubMed ID: 18381510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: a prospective cohort study.
    Lee SW; Han JY; Choi JS; Chung JH; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
    Reprod Toxicol; 2009 Apr; 27(2):196-8. PubMed ID: 19162171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionizing radiations in pregnancy and teratogenesis: a review of literature.
    De Santis M; Di Gianantonio E; Straface G; Cavaliere AF; Caruso A; Schiavon F; Berletti R; Clementi M
    Reprod Toxicol; 2005; 20(3):323-9. PubMed ID: 15925481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive risks associated with exposure to antineoplastic agents: a review of the literature.
    Hoffman DM
    Hosp Pharm; 1986 Oct; 21(10):930-2, 936, 940. PubMed ID: 10301074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teratogen update: lead and pregnancy.
    Bellinger DC
    Birth Defects Res A Clin Mol Teratol; 2005 Jun; 73(6):409-20. PubMed ID: 15880700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between maternal physical activity during pregnancy and birth weight.
    Dwarkanath P; Muthayya S; Vaz M; Thomas T; Mhaskar A; Mhaskar R; Thomas A; Bhat S; Kurpad A
    Asia Pac J Clin Nutr; 2007; 16(4):704-10. PubMed ID: 18042532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes.
    Taguchi N; Rubin ET; Hosokawa A; Choi J; Ying AY; Moretti ME; Koren G; Ito S
    Reprod Toxicol; 2008 Oct; 26(2):175-7. PubMed ID: 18640262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possible teratogenic effects of thiamazole].
    Ozgen HM; Reuvers-Lodewijks WE; Hennekam RC
    Ned Tijdschr Geneeskd; 2006 Jan; 150(2):101-4. PubMed ID: 16440566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium periconceptional exposure: pregnancy and neonatal outcome.
    De Santis M; Straface G; Cavaliere AF; Carducci B; Caruso A
    Acta Obstet Gynecol Scand; 2007; 86(1):99-101. PubMed ID: 17230297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors.
    Cooper WO
    J Cardiovasc Nurs; 2008; 23(1):20-4. PubMed ID: 18158502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk.
    Khalil A; Cowans NJ; Spencer K; Goichman S; Meiri H; Harrington K
    Prenat Diagn; 2009 Aug; 29(8):781-9. PubMed ID: 19418482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medical-social aspects of reproductive health in pregnant women with perinatal pathology].
    Kerimova LR; Kamilova NM; Sulganova IA; Kulieva SD
    Georgian Med News; 2006 Sep; (138):34-6. PubMed ID: 17057293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.